MAPK Signaling

Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
B7720 CEP 1347Summary: JNK inhibitor -
A5573 Pimasertib (AS-703026)Target: MEKSummary: MEK1/2 inhibitor -
A8716 LY3009120Target: RafSummary: pan-RAF and RAF dimer inhibitor -
B6187 BMS-582949Summary: p38 MAPK inhibitor -
B7444 SU 3327Summary: JNK inhibitor -
A8545 ZM336372Summary: C-Raf inhibitor, potent and selective -
B6012 Pexmetinib (ARRY-614)Target: p38|Tie-2Summary: dual inhibitor of p38 MAPK and Tie2/Tek receptor tyrosine kinase -
B7321 TCS JNK 6oTarget: JNKSummary: JNK inhibitor -
A3887 Trametinib DMSO solvate1 CitationTarget: MEKSummary: Allosteric MEK1/MEK2 kinase inhibitor -
A8371 AZ 628Summary: Raf kinases,potent and ATP-competitive
